Results 11 to 20 of about 76,163 (331)

Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer [PDF]

Journal of Stroke, 2018
Background and Purpose Interventions to reduce the risk for cerebrovascular events (CVE; stroke and transient ischemic attack [TIA]) after radiotherapy (RT) for head and neck cancer (HNCA) are needed. Among broad populations, statins reduce CVEs; however,
Daniel Addison, Patrick R. Lawler, Hamed Emami, Sumbal A. Janjua, Pedro V. Staziaki, Travis R. Hallett, Orla Hennessy, Hang Lee, Bálint Szilveszter, Michael Lu, Negar Mousavi, Matthew G. Nayor, Francesca N. Delling, Javier M. Romero, Lori J. Wirth, Annie W. Chan, Udo Hoffmann, Tomas G. Neilan   +17 more
doaj   +1 more source

Harmonising Multisite Brain MRI Data: Insights from the Dementias Platform UK (DPUK) PET‐MR harmonisation Study [PDF]

Alzheimers Dement
Bhalerao G, Markiewicz P, Thomas D, de Vita E, Parkes L, Thompson G, MacKewn J, Krokos G, Wimberley C, Hallett W, Su L, Smith S, Malhotra P, Hoggard N, Taylor J, Ritchie C, Wardlaw J, Matthews P, Aigbirho F, O'Brien J, Hammers A, Fox N, Herholz K, Barkhof F, Miller K, Matthews J, Griffanti L.   +26 more
europepmc   +3 more sources

Breast PET/MR Imaging [PDF]

Radiologic Clinics of North America, 2017
Breast and whole-body PET/MR imaging is being used to detect local and metastatic disease and is being investigated for potential imaging biomarkers, which may eventually help personalize treatments and prognoses. This article provides an overview of breast and whole-body PET/MR exam techniques, summarizes PET and MR breast imaging for lesion detection,
Amy, Melsaether, Linda, Moy
openaire   +2 more sources

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR

Frontiers in Oncology, 2022
PurposeThis study aims to determine the diagnostic performance of whole-body FDG PET/CT plus delayed abdomen PET/MR imaging in the pretherapeutic assessment of pancreatic cancer in comparison with that of contrast-enhanced (CE)-CT/MR imaging.Materials ...
Zaizhu Zhang, Nina Zhou, Xiaoyi Guo, Nan Li, Hua Zhu, Zhi Yang   +5 more
doaj   +1 more source

“Low Dose MR” Dixon Technique for Imaging FDG PET-MR Lymphoma

World Journal of Nuclear Medicine, 2022
Introduction Hybrid PET-MR is a relatively new imaging modality with its major strength being the MR component offering superior soft tissue contrast. While PET/MRI offers the inherent advantage of reduced radiation dose, it has been shown to result in a
Musa Ali Mufti, Robert Matthews, Ezemonye Madu, Kavitha Yaddanapudi, Dinko Franceschi   +4 more
doaj   +1 more source

NEMA NU 2-2007 performance characteristics of GE Signa integrated PET/MR for different PET isotopes [PDF]

, 2019
BackgroundFully integrated PET/MR systems are being used frequently in clinical research and routine. National Electrical Manufacturers Association (NEMA) characterization of these systems is generally done with F-18 which is clinically the most relevant
D'Asseler, Yves, De Vasconcelos Caribé, Paulo Rauli Rafeson, Deller, Timothy W, Koole, M., Van Laere, K, Vandenberghe, Stefaan   +5 more
core   +1 more source

PET/MR outperforms PET/CT in suspected occult tumors [PDF]

, 2017
BACKGROUND To compare the diagnostic accuracy of PET/MR and PET/CT in patients with suspected occult primary tumors. METHODS This prospective study was approved by the institutional review board. Sequential PET/CT-MR was performed in 43 patients (22 male
Burger, Irene A, De Galiza Barbosa, Felipe, Delso, Gaspar, Huellner, Martin W, Mader, Cäcilia E, Sah, Bert-Ram, Sekine, Tetsuro, Stolzmann, Paul, Ter Voert, Edwin E, Veit-Haibach, Patrick, von Schulthess, Gustav K   +10 more
core   +1 more source

Design and system evaluation of a dual-panel portable PET (DP-PET)

EJNMMI Physics, 2021
Background Integrated whole-body PET/MR technology continues to mature and is now extensively used in clinical settings. However, due to the special design architecture, integrated whole-body PET/MR comes with a few inherent limitations.
Tianyi Zeng, Jiaxu Zheng, Xinyuan Xia, Xin Chen, Beien Wang, Shuangyue Zhang, Adam Chandler, Tuoyu Cao, Lingzhi Hu, Qun Chen, Xu Chu   +10 more
doaj   +1 more source

Non-small-cell lung cancer resectability: diagnostic value of PET/MR. [PDF]

, 2014
Purpose To assess the diagnostic performance of PET/MR in patients with non-small-cell lung cancer. Methods Fifty consecutive consenting patients who underwent routine 18F-FDG PET/CT for potentially radically treatable lung cancer following a staging ...
Barnes, A, Bomanji, JB, Fraioli, F, Groves, AM, Janes, SM, Kayani, I, Menezes, L, O'Meara, C, Punwani, S, Screaton, NJ, Syed, R, Win, T, Zaccagna, F   +12 more
core   +2 more sources

PET/MR: a paradigm shift [PDF]

Cancer Imaging, 2013
More than a decade ago, multimodality imaging was introduced into clinical routine with the development of the positron emission tomography (PET)/computed tomography (CT) technique. Since then, PET/CT has been widely accepted in clinical imaging and has emerged as one of the main cancer imaging modalities.
Florian C. Gaertner, Sebastian Furst, Markus Schwaiger   +2 more
openaire   +3 more sources